University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.
The Health Cyberinfrastructure (CI) Division of the San Diego Supercomputer Center (SDSC) at the University of California San Diego, has partnered with Microsoft Azure Cloud Services (Azure) to expand its portfolio of cloud services.
A team of scientists at Scripps Institution of Oceanography at the University of California San Diego and the J. Craig Venter Institute (JCVI) has developed a new way to produce kainic acid, a natural seaweed neurochemical and powerful reagent used in brain research.
Two renowned research centers at University of California San Diego are joining forces to take a deeper look at how components of human milk and the microbiome can change the course of therapeutics for infant and adult diseases.
Diagnoses of autism spectrum disorder (ASD) by trained professionals in children as young as 14 months are remarkably stable, suggesting that accurate screening and earlier treatment is feasible, report scientists at University of California San Diego School of Medicine.
Researchers at University of California San Diego School of Medicine found using blood thinners in patients with worsening heart failure, coronary artery disease and irregular heart rhythms was associated with a reduced risk of thromboembolic events, such as stroke and heart attack.
University of California San Diego School of Medicine researchers and collaborators describe a new set of “rules” that predict how the tissue of origin influences critical aspects of the genetic makeup of tumors, with potentially important therapeutic implications.
University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.
Susan Ackerman, Yishi Jin and John Wixted of UC San Diego have been elected to the American Academy of Arts and Sciences, one of the country’s most esteemed honorary societies and independent policy research centers. They will join 200 new members in the organization’s 2019 class.